Visit the Caliper Life Sciences web site
Click on the advert above to visit the company web site

Product category: Microfluidics/Lab-on-a-chip systems
News Release from: Randox Laboratories | Subject: Biochip array technology
Edited by the Laboratorytalk Editorial Team on 11 June 2007

Biochip array tests multiple analytes at
once

Biochip array technology from Randox allows multiple results from a single patient sample, minimising biological variation and resulting in a more rapid and accurate diagnosis

The FDA-cleared biochip array technology was designed by Randox Laboratories and was granted the prestigious MacRobert award for engineering in 2003 Based on Elisa principles of competitive, sandwich and antibody capture assays biochip array technology utilises a 9mm2 biochip as a reaction platform, with multiple specific ligands (antibodies or antigens) attached at pre-defined sites on the surface

Up to 23 separate tests can be spotted as discrete test regions on the surface of the biochip allowing 23 different results from as little as 7ml of patient sample.

Biochip tests are grouped together as arrays and allow the detection of cytokines and growth factors, fertility and thyroid hormones, cell adhesion molecules and drugs of abuse.

Arrays are also available for the detection of biomarkers associated with cardiovascular disease and cancer.

The Biochip platform is suitable for both proteomic and genomic analysis, providing test standardisation for better performance and accuracy.

Randox says it has a very strong R+D ethos with 200 R+D staff and currently have more tests in development than any other diagnostic company in the world. Request a free brochure from Randox Laboratories ...

Randox Laboratories: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Caliper Life Sciences web site